NCT05745844View on ClinicalTrials.gov

Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Prostate Cancer
Interventions
OTHER

activity sessions

77 activity sessions ; muscle strengthening, testing or unloading

Trial Locations (1)

74100

RECRUITING

Hôpital privé Pays de Savoie, Annemasse

Sponsors

Collaborators (1)

Euraxi Pharma
All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT05745844 - Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program | Biotech Hunter | Biotech Hunter